Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry
Conclusions:
Patients undergoing protected high-risk percutaneous coronary intervention with Impella support showed an acceptable 180-day clinical outcome regarding major adverse cardiac event and mortality.
Source: Coronary Artery Disease - Category: Cardiology Tags: PCI Source Type: research
More News: Angioplasty | Cardiology | Coronary Angioplasty | Germany Health | Heart Attack | Percutaneous Coronary Intervention | Stroke | Study